Page last updated: 2024-10-16

quinacrine and Malignant Mesothelioma

quinacrine has been researched along with Malignant Mesothelioma in 2 studies

Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Kulkarni, NS1
Vaidya, B1
Parvathaneni, V1
Bhanja, D1
Gupta, V1
Busacca, S1
Zhang, Q1
Sharkey, A1
Dawson, AG1
Moore, DA1
Waller, DA1
Nakas, A1
Jones, C1
Cain, K1
Luo, JL1
Salcedo, A1
Salaroglio, IC1
Riganti, C1
Le Quesne, J1
John, T1
Boutros, PC1
Zhang, SD1
Fennell, DA1

Other Studies

2 other studies available for quinacrine and Malignant Mesothelioma

ArticleYear
Repurposing Quinacrine for Treatment of Malignant Mesothelioma: In-Vitro Therapeutic and Mechanistic Evaluation.
    International journal of molecular sciences, 2020, Aug-31, Volume: 21, Issue:17

    Topics: Antineoplastic Agents; Apoptosis; Cell Movement; Cell Proliferation; Drug Repositioning; Humans; In

2020
Transcriptional perturbation of protein arginine methyltransferase-5 exhibits MTAP-selective oncosuppression.
    Scientific reports, 2021, 04-01, Volume: 11, Issue:1

    Topics: Biomarkers, Tumor; Cell Transformation, Neoplastic; Gene Deletion; Gene Expression Regulation, Neopl

2021